Organigram's Q3 sales rose 72% to $51.14 million, driven by Motif acquisition and global demand, with margin gains and positive cash flow expected.

Organigram is a licensed cannabis producer based in Moncton, New Brunswick. It partnered with British American Tobacco in 2023 to develop new cannabis products and also bought The Edibles and ...

Q3 2025 Earnings Call Transcript August 13, 2025 Organigram Global Inc. misses on earnings expectations. Reported EPS is ...

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market ...

TORONTO (AP) — TORONTO (AP) — Organigram Global Inc. (OGI) on Wednesday reported a loss of $4.5 million in its fiscal third quarter. On a per-share basis, the Toronto-based company said it had a loss ...

OrganiGram Holdings ( ($OGI) ) has released its Q3 earnings. Here is a breakdown of the information OrganiGram Holdings presented to its ...

Organigram represents 12.2% of my Beat the Global Cannabis Stock Index model portfolio that I share with subscribers to 420 Investor. In this follow up, I explain why I still hold it in such a ...

OrganiGram’s revenue growth is very impressive. With plenty of cash in hand, in my view, the company’s acquisitions and further product development will likely serve as revenue catalysts.

Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly-owned subsidiaries include Organigram Inc. and Laurentian Organic Inc. licensed producers of cannabis ...

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram has higher margins than most of its peers and one of the lowest costs per gram in the industry even though it grows indoors, generally considered the most expensive method of production ...